Category Archives: Reproductive Health

‘The pill is a badge of honour for some girls, but that still doesn’t make us sluts’

‘The pill is a badge of honour for some girls, but that still doesn’t make us sluts’

2014-04-09

A US study has found being on the pill doesn’t make girls any more promiscuous – as some critics have suggested. Well, duh, says Daisy Buchanan, as she praises the NHS for always giving out free contraception

By Daisy Buchanan

Excellent news from the US! Apparently, the availability of free or affordable hormonal contraception does not turn women into insatiable succubi who, given the excuse and opportunity, will become promiscuous enough to make Anthony Weiner look like a giant panda. A study released in the Obstetrics And Gynaecology journal found that, over a year of birth control courtesy of ObamaCare, 70 per cent of women reported no change in the number of partners they slept with – and most of the 13 per cent of women sleeping with more people said it was because their numbers had ‘rocketed’ from zero to one.

You wouldn’t think the effects of contraception on promiscuity would even merit a study, but then you probably wouldn’t think it was OK to say that being on the pill makes a woman a slut – as Rush Limbaugh did before he apologised. Or imply, like Republican Mike Huckabee, that women who need financial help with contraception simply can’t control their sex drives.

When I was at school, being on the pill was a badge of honour – and dishonour. The girls with steady boyfriends who were rumoured to be ‘doing it’ but couldn’t be drawn on the subject could sometimes be tricked into revealing the details of their choice of hormonal contraception. Bags, lockers and pencil cases were regularly searched for sexy evidence. Anyone who asked any suspiciously attentive questions in biology class was suspected.

Of course, some poor girls were on it just to regulate heavy periods, but we wouldn’t listen to the boring, practical truth. As far as we were concerned, if you were on the pill, you were a slut, and we whispered about you and judged you. The obvious feeling we failed to articulate was jealousy. The girls on the pill seemed thrillingly adult, and we knew we weren’t cool enough for their world, so we excluded them from ours.

Of course, after a couple of years, everyone was on the pill, or the implant, or the coil, or, for the adventurous, the Nuva ring. Using hormonal contraception doesn’t make me feel like an edgy rebel – but having just renewed my Nexplanon implant for the fourth time, I feel full of thankfulness for the NHS, who make the procedure easy as well as free. Giving women autonomy over their bodies and allowing them to choose to start a family if and when they’re ready is one of the most enlightened, progressive things any country can provide for its ladies. Sadly, we know that we have sisters all over the world who don’t have so many straightforward options.

In the States, Planned Parenthood clinics are being shut down at a record rate. This is partly due to direct pressure from anti-abortion activists, and partly down to a lack of funding – although the centres provide contraception as well as abortion advice and services, they are targeted by pro-life activists. As the NHS faces drastic budget cuts, I fear our sexual health clinics could be under threat too.

The recent, chilling story from Wonder Women about unregulated crisis centres giving women inaccurate abortion advice is a reminder that our right to judgement-free family planning is one that’s definitely worth protecting. Pregnancy should be a joyful life event, and not a biological punishment for having sex, and daring to enjoy your body in an independent way.

Being on the pill doesn’t make anyone a slut. It does demonstrate that you’re responsible enough to plan ahead, work out what your priorities are and focus on your education, career or any one of the hundreds of other important things you might want to do before, or instead of having a child. The pill doesn’t just give women the freedom to have sex without experiencing an unwanted pregnancy. It allows them a life that would not have been possible at the start of the last century.

Daisy Buchanan is a freelance journalist who can be found tweeting @NotRollerGirl


Abortion: A pregnant woman’s right to choose – free of any pressure

Abortion: A pregnant woman’s right to choose – free of any pressure

I unreservedly support a woman’s right to terminate her pregnancy, and I have no moral issue with abortion. But it’s precisely because I support a woman’s right to choose that I feel uncomfortable about the way that abortion services are run.

There can be few medical procedures so politically charged as abortion. Simply uttering the term polarises people. Battle lines are drawn and there is an expectation that you will join one camp or the other. For or against, pro-life or pro-choice: the narrative rarely extends beyond this simple dichotomy. And, if you are pro-choice, any criticism of abortion is considered a heresy.

I unreservedly support a woman’s right to terminate her pregnancy, and I have no moral issue with abortion. But it’s precisely because I support a woman’s right to choose that I feel uncomfortable about the way that abortion services are run. That there is a financial incentive for pregnancy advisory services to undertake terminations is plain wrong. It is fair to ask, how can they offer independent advice when so much of their income comes from terminations?

Many women seeking advice are scared, upset and vulnerable. While doctors would argue that they remain impartial in the advice they give, research suggests that, although many think they are impartial, in fact they can be easily swayed by subtle external pressures. Why do we think it will be any different with abortion?

It’s not just that women might be swayed into having a termination. The opposite is also true.

Crisis Pregnancy Centres are a group of unregulated outlets across the UK that promote themselves as advisory services for women trying to deal with an unplanned or unwanted pregnancy. While some may claim to be impartial, others are run by pro-life charities. These centres are not regulated by the Department of Health, yet claim to give out reliable health advice.

Worryingly, investigations by this newspaper have shown that the information they share about the physical and mental effects of an abortion is often not supported by medical evidence or in line with official advice from the Royal College of Obstetricians.

What an unforgivable mess. Where are the voices from women’s groups condemning this whole set-up? Where were the feminists after this newspaper also uncovered doctors who were willing to terminate pregnancies for women who did not want to have a baby girl? A few muted whimpers – but nothing more.

Last month, another investigation suggested that the practice has become so widespread within some communities that it is said to have led to the “disappearance” of between 1,400 and 4,700 females. Why aren’t men and women who consider themselves supporters of women’s rights up in arms about this?

What was exposed is pure misogyny, and yet, because it relates to abortion, ideological confusion creeps in. Why can’t you criticise the way abortion services are run while still supporting a woman’s right to choose?

For me, this is a clear example of how farming out services from the NHS to independent providers can go cataclysmically wrong. The entirety of pregnancy advice should be brought back into the NHS, where strict guidelines on impartiality can be enforced and there is no financial incentive for individuals to recommend one decision over another.

I’m pro-choice – and I want things to change to ensure that that choice really is the woman’s.

Women Who Stand By Their NuvaRing

Women Who Stand By Their NuvaRing

2014-02-13

Some are finding it difficult to dump a contraceptive that has been known in some cases to lead to death

ring-300x200

There’s the 24-year-old who stopped breathing, had two heart attacks, and died on life support. There’s the mother whose two-year-old son watched her go into a seizure. And there’s the college student who started spitting up blood while having lunch with her dad.

The accounts of women experiencing the negative side effects of the NuvaRing contraceptive are gruesome, and their stories are part of the evidence that led to the $100 million settlement last week with NuvaRing maker Merck & Co. The pharmaceutical company agreed to hand over $100 million for liability lawsuits claiming the ring caused blood clots that sometimes led to heart attacks and even death, although Merck denied fault. The women argued they were not adequately warned about these side effects, and about 3,800 of them are eligible to partake in the settlement.

Despite the well-publicized risks, some women are finding it difficult to ditch a contraceptive that has provided them with consistency and convenience. Oftentimes, finding the right birth control takes years of trial and error, and side effects range from weight gain to decreased libido. For this reason, when women find the right contraceptive, they tend to develop a certain loyalty to it.

Sarah, 26, a graduate student in New York City, struggled with finding the right birth control since she was 20 years old. During the year she was on the pill, she put on weight and was constantly having mood swings. She’d feel depressed one day and highly irritable the next. She switched to the NuvaRing five years ago after a friend suffering similar effects made the swap, and it has been smooth sailing ever since. “I hated the whole contraceptive experience, but with the NuvaRing I don’t experience any of that,” she says.

The NuvaRing ring is a flexible ring that women insert inside their vagina and remove for the week of their period. Like an oral contraceptive, it releases the hormones progestin and estrogen (though at lower levels), preventing ovulation and sperm from reaching the egg, but you don’t have to remember to take a pill every morning. Women prefer it for its convenience, the localized hormones, and the fact that there’s less accountability. In 2012, there were about 5.2 million prescriptions in the U.S. for the NuvaRing, according to IMS Health, a healthcare technology and information company.

According to the American College of Obstetricians and Gynecologists (ACOG)–the medical authority on all things related to baby-making–NuvaRing leads to a slight increased risk of deep vein thrombosis, heart attack, and stroke. And, as highlighted in a safety warning on NuvaRing’s website, the danger is higher for some women, like those over 35 who smoke more than 15 cigarettes a day or women who have multiple risk factors for heart disease. Its typical use failure rate is 9%, the equivalent of an oral contraceptive, according to the CDC.

Following the settlement Friday, Merck issued a statement saying, “We stand behind the research that supported the approval of NuvaRing, and our continued work to monitor the safety of the medicine.”

Though the side effects of the NuvaRing are very real, for many women it bears no complications. “I am extremely busy with very irregular hours and travel for my job,” says Julie*, 27, who works for a film production company in Los Angeles, California, “so the NuvaRing is the ideal fit for my lifestyle. I have virtually no side effects, so I plan to remain on it for the foreseeable future.”

Other women simply shrug off the dangers. “Every drug you take comes with risks, from Asprin to birth control to allergy medicine,” says Ricci Ellis, 31, a respiratory therapist in Little Rock, Arkansas, who switched from the pill after consistently forgetting to take it. “For me, the benefits of NuvaRing far outweigh the risks.” Because she’s not not a smoker and leads an active and healthy lifestyle, Ellis considers herself relatively safe from the risks of blood clots, strokes, and sudden death.

“It is absolutely essential that people are aware of the risks associated with each method of contraception,” says Bill Albert, the chief program officer at The National Campaign to Prevent Teen and Unplanned Pregnancy. The American Heart Association (AHA) recently recommended that women considering birth control get screened for high blood pressure, which can put them at a greater risk for clots and stroke. ”Equally important, however, is how such risks compare to those of other methods, and to pregnancy as well.”

According to Albert, the side effects need to be placed in a broader context so that they are neither dismissed nor viewed with disproportionate alarm. “One of the highest risk of blood clots comes with pregnancy. Consequently, if an individual is having sex and doesn’t want to get pregnant, skipping birth control altogether for fear of blood clots is not the best way to protect your health,” says Albert. “This is not meant to be cavalier, but the doubling of a rare risk is still rare.”

Medical experts are careful to not trivialize the risks, but Dr. Eve Espey, the chair of ACOG’s Committee on Health Care for Underserved Women and a professor in the Department of Ob-Gyn at the University of New Mexico’s School of Medicine, says the NuvaRing settlement hasn’t changed how she counsels her patients. “It’s always tragic and horrible when a woman has a bad outcome or dies from a blood clot. But to then label that method as dangerous often translates into more unintended pregnancies with a higher risk than using the method,” says Dr. Espey. Though popular for its convenience, the NuvaRing isn’t the most effective form of birth control out there. And neither is the pill. The intrauterine device (IUD) and the implant are considered the two safest and most effective forms of birth control available, with a typical use failure rate of 0.8% and 0.05% respectively.

When asked if women currently using NuvaRing should talk to their doctors about other options, Dr. Espey said, “How do you prepare for the event that’s so rare?”

But it’s making Sarah think twice. “I’m definitely concerned about the risks,” she says. “I am making an appointment with my gynecologist to discuss options.”

*Name has been changed for privacy.

What Women Still Don’t Know About Getting Pregnant Read more: Women confused about fertility and reproductive health

What Women Still Don’t Know About Getting Pregnant Read more: Women confused about fertility and reproductive health

2014-01-29

By

As surprising as it seems, about half of women of reproductive age have not talked to their health care provider about their reproductive health, according to a new study.

As a result, the researchers, from the Yale School of Medicine, found that women between ages 18 and 40 weren’t aware of some the important factors that influence fertility and their ability to get pregnant, as well as about basic prenatal practices once they were expecting.

Among the most notable findings, which were published in the journal, Fertility & Sterility :

  • 30% of the women reported that they only visited a reproductive health provider less than once a year or not at all.
  • 50% of the women did not know that taking multivitamins and folic acid are recommended to avoid birth defects.
  • A little over 25% of women did not know that things like STDs, smoking and obesity impact fertility.
  • 20% did not know that aging can impact fertility and increase rates of miscarriage
  • 50% of the women thought that having sex multiple times in a day increased their likelihood of getting pregnant
  • Over 33% of women thought that different sex positions can increase their odds of getting pregnant
  • 10% did not know that they should have sex before ovulation to increase the chances of getting pregnant instead of after ovulation

The significant gaps in the women’s knowledge about their fertility may also explain why 40% reported that they had concerns and questions about their ability to get pregnant. The researchers believe that as women put off starting families — the latest CDC report showed women between 25 to 29 years old have the highest pregnancy rates, compared to women aged 20 to 24 in earlier years — doctors, particularly reproductive health specialists, should have more opportunity for improving women’s education about fertility and pregnancy so they know what to expect when they are finally ready to have a child.

Effectiveness of Emergency Contraception for Overweight Women Reviewed in Europe Read more: Effectiveness of Emergency Contraception for Overweight Women Reviewed in Europe

Effectiveness of Emergency Contraception for Overweight Women Reviewed in Europe Read more: Effectiveness of Emergency Contraception for Overweight Women Reviewed in Europe

2014-01-27

By

The European Medicines Agency (EMA) — the European version of the U.S. Food and Drug Administration (FDA) — launched a broad review of whether body weight influences the ability of emergency contraceptives to prevent unintended pregnancies.

The agency recently required makers of the European version of Plan B, called Norlevo, to add an alert that the product may be less effective for overweight women. The move was spurred by a 2011 study that found that women with a body mass index (BMI) greater than 25 who used levonorgestrel, which prevents pregnancy by blocking the release of the egg from the ovary, inhibiting fertilization or changing the uterine lining to discourage pregnancy, were four times more likely to get pregnant than women with lower BMIs.

Now, based on that study and other data, the EMA is turning its attention to other emergency contraceptive measures that rely on hormones to prevent pregnancy. These include Norlevo, Levonelle/Postinor and Levodonna which all contain the hormone levonorgestrel. All the medications are available over the counter, and the agency is also studying one prescription-based medication called ellaOne that includes ulipristal acetate.

It’s unclear why emergency contraception could be less effective in overweight women, but the U.S. FDA is also reviewing existing data to determine if any changes in labeling or action is necessary. Calls to the FDA were not immediately returned.

Reproductive health experts say women who are concerned about whether their emergency contraceptive will prevent pregnancy should consider other birth control methods known to be more effective, like the IUD.

Morning-After Pill May Not Work For Women Over 176 Pounds Read more:

Morning-After Pill May Not Work For Women Over 176 Pounds Read more:

2013-11-26

Widespread implications if true

A European company that makes an emergency contraceptive identical to the morning-after Plan B pill is set to warn consumers that the drug is completely ineffective for women over 176 pounds, and begins to lose effectiveness after 165 pounds, Mother Jones reports.

The European drug, Norlevo, will be repackaged to reflect the weight limits, according to the report, which could carry significant implications for American women if true and if also applicable to morning-after pills in the U.S. Norlevo is chemically identical to many of the most popular emergency contraceptive brands used in the U.S., including Plan B One-Step, Next Choice One-Dose, and My Way. American manufacturer of emergency contraceptives didn’t comment to Mother Jones, and the FDA has yet to weigh in on the matter.

According to weight data from the Centers for Disease Control and Prevention, the average American woman weighs 166 pounds, and the average non-Hispanic black woman between 20 and 39 weighs about 186 lbs. If the European manufacturer is correct, morning-after pills could be ineffective for many American women.

Plan B One-Step is the only emergency contraceptive available over-the-counter to women of all ages. Norlevo packages will include a pamphlet summarizing the new discovery.

Why It Takes Teens Equipped With Condoms to Encourage Family Planning in Africa Read more: Why It Takes Teens Equipped With Condoms to Encourage Family Planning in Africa

Why It Takes Teens Equipped With Condoms to Encourage Family Planning in Africa Read more: Why It Takes Teens Equipped With Condoms to Encourage Family Planning in Africa

2013-11-19

By

 

fp-150x150

Ethiopia has over 77 million inhabitants, and is considered one of the poorer countries in Africa. But this year, it’s playing host to the annual International Family Planning Conference in its capital, Addis Ababa.

The conference showcases the fact that despite Ethiopia’s high poverty rate and political intrusions on free speech, it has one of the most progressive family planning policies in Africa. And that success is serving as a model, not only for other developing nations such as Rwanda and Malawi, but for developed ones as well.

Economically, family planning is critical for a country’s stability — by protecting women from unwanted pregnancies that can contribute to high maternal and child mortality rates, these programs also allow mothers to enter the work force, and empower them to contribute to their local economy. Family planning is a public health term for essentially means controlling the number of births a woman has, and spacing those births. The Bill and Melinda Gates Foundation estimate that 1 in 4 women’s lives could be saved if there were global access to contraception, for example. And family planning isn’t just focused on mothers. The Foundation found that about 3.2 million children die each year from preventable diseases, many of which could be avoided if families had access to proper medical care, such as immunizations and antibiotics.

Such efforts have translated into measurable changes already. In Ethiopia, public health facilities offer all available contraceptive methods for free, and that has contributed to a rise in contraceptive use among women. The percentage of women of reproductive age using family planning has jumped from 8% in 2000, to 15% in 2005, to 29% in 2011.

For men, the Ethiopian government sends male mentors directly to people’s homes, to educate those who are skeptical or against the idea of their wives planning their births. Family planning is also introduced to boys in primary school. Despite these attempts, however, male involvement in family planning is still considered a challenge for countries in the developing world.

What has worked to improve the way couples start their families and enhance childhood health? Here’s what Ethiopia, Rwanda and Malawi are doing right to strengthen family planning.

Recognizing that young people are sexually active: While it seems obvious, acknowledging that teens are having sex is a challenge for some administrations, especially conservative ones. A typical 18-year-old Ethiopian woman is already married and likely expecting her first child, and most women have around five. However, community health centers in that country now include youth services and private offices to not only educate teens, but provide them with the protection they need to practice safe sex or delay sexual activity.

Appreciating that most teens may not feel comfortable talking about sex with adults, some NGOs and organizations have taken more unconventional approaches to getting contraceptives to young people. Planned Parenthood Federation of America, for instance, partners with Mary Joy Aid Through Development to train Ethiopian teens to become peer health promoters. As promoters, they talk to other teens about sexual health issues and distribute contraceptives like pills and condoms.

“I’ve been surprised by young men asking what methods of contraceptives they should use,” says Josephat Nyamwaya, a program officer for the Planned Parenthood Federation of America’s Africa office, where he trains youth in many African communities like his roots in Nairobi. “I tell them at their age, condoms, but that they also need to support their girlfriends in their contraceptive decisions.”

Making family planning the law: In Ethiopia’s constitution, access to family planning is cited as a woman’s right. Similarly, Rwanda’s government has legislated strong policies for family planning, and saw uptake of contraceptives jump by 10-fold. In 2000, only 4% of married women of reproductive age were using modern contraceptive methods, but the rate spiked to 45% by 2010, thanks to the country’s National Family Planning Program, which revamped access to contraceptives by stocking up all public health clinics, trained more providers in family planning education, and encouraged more women to give birth in their health facilities rather than at home.

And to persuade couples to space children apart, or use contraceptives, the government of Malawi has focused on improving child health services. Ironically, the more dire their circumstances, the more children parents are likely to have, because they know that many won’t survive their first years. “You cannot tell people not to have [more] children if they don’t feel secure that they will survive,’ says Malawi Minister of Health, Catherine Gotani Hara.

Giving family planning prominence in the country’s constitution is an important step toward acknowledging the critical role that reproductive health plays in a country’s economic stability. “These countries that are having success have really come out front with the recognition that if they were to solve this problem, they would solve so many others in their country. When you don’t have that leadership, it’s really difficult to move forward,” says Beth Fredrick, director of advance family planning for the Bill & Melinda Gates Institute at Johns Hopkins School of Public Health.

Bringing family planning services to the people: In both Ethiopia and Malawi, health extension workers are the key to reaching community members and getting them to clinics, as well as providing them with access to family planning programs. In Ethiopia, every community is allocated a hospital, a smaller health center, and a health post—which is staffed by two health extension workers. To supplement their efforts, the governments of these countries, using funds from the U.S. Agency for International Development (USAID), developed the Women’s Development Army. Members of the army, which include local community mothers who are trained by extension workers, go door to door, educating women about family planning, and hosting small gatherings of five community members to discuss reproductive health and answer questions in an informal setting.

‘I had my first [of five children] when I was just 15 and didn’t know about family planning,’ says Yenenesh Deresa, a member of the Women’s Development Army of Burayu, Ethiopia. “Now we sit around coffee and I talk to women about family planning. They’re empowered to make their own decisions and have safer pregnancies.”

Realizing the value of educating girls: If countries like Ethiopia, Rwanda and Malawi can lower their fertility rate, there’s a possibility that they could experience a bump in the economy, known as reaching the demographic dividend. That’s when younger generations join the workforce, and the greater proportion of this cohort that can find employment and live independently, the fewer dependents a country has. The first step toward achieving this condition is to lower fertility rates, but the younger generation needs to be educated to succeed in the workforce and there needs to be jobs available as well. While educating both genders is critical for such success, making sure that girls receive their degrees is especially important, since about a quarter of girls in low-resource countries drop out of school once they get pregnant.

“Empowerment [of women without education] is complicated. If girls need to be educated and attend schools, they need to be protected from unplanned pregnancies,” says First Lady of Ethiopia, Roman Tesfaye. “If we do not address these issues for women, it will be too challenging to become a middle income country.”

The push to protect women through health measures that will keep her in schools is slowly playing out even in rural communities. “You can see that things are changing now for women. I am a woman, and I am a leader here,” says Zewdtu Areda, head of health zone near Muka Turi, Ethiopia where she oversees health services offered for the area.

Offering all forms of birth control: Even in the U.S., research shows that when all methods of contraception are offered at low cost, women tend to pick long-acting reversible contraceptives (like implants and IUDs) over condoms and pills. Ethiopia, Rwanda and Malawi all provide contraceptives at no cost in public health clinics, and in line with prior research, women tend to choose the longer-acting, more discreet methods. However, clinics continue to offer the less popular methods in order to give women a full spectrum of choices, so women can decide for themselves which methods are best for them.

Changing cultural acceptance of family planning: Health clinic workers often hear the same requests from women — they want birth control, but don’t want their husbands to know they are using a contraceptive. Even with progressive policies, in countries like Ethiopia cultural stigmas against limiting reproduction remain. Health workers often meet young women in public, outside of the clinic, to give women birth control so her husband won’t know she visited a family planning program.

Changing cultural norms remains a challenge, but officials in Rwanda rely on community health workers to talk to men about why they should support family planning and about how planning their children can mean having healthier children and potentially fewer children to support. They even encourage male family planning methods such as vasectomies. When men come in with their wives to discuss family planning measures, health workers cite the surgery as an option, and encourage it alongside circumcision to prevent diseases like HIV although it’s still not a popular choice.

In Malawi, public health officials are enlisting the help of respected elders. A campaign headed by community chiefs that promotes family planning for couples, for example, includes the voice and perspective of men. “In the villages, we try to include as many men as possible. Men are very affected. In rural settings in Malawi, the breadwinner is usually the man. So if they cannot control their family, they’re the ones in trouble,” says Gotani Hara.

Public health officials are hopeful that the success of these initiatives in the developing world could spill over to industrialized nations as well — including the U.S. — that still struggle to reduce rates of sexually transmitted diseases, unplanned pregnancies and infant mortality. If there is one lesson to learn from these programs, it’s that the most successful strategies don’t come from doctors or government officials, but from peers — mothers, friends or respected elders –  who, it turns out, have the strongest voice when it comes to talking about sex and families.

Long-term Pill use may double glaucoma risk

Long-term Pill use may double glaucoma risk

Women who used birth control pills for three years or more have twice the risk of developing glaucoma later in life, according to new research.

Glaucoma is a disease that damages the eye’s optic nerve and is a leading cause of blindness in the United States.

It’s been well documented that low-estrogen levels following menopause contribute to glaucoma in women. Scientists don’t know exactly why this happens.  But years of using birth control pills, which can also lower estrogen levels, may add to the problem.

The study, conducted by researchers at University of California, San Francisco, Duke University School of Medicine and Third Affiliated Hospital of Nanchang University, Nanchang, China, did not differentiate between women who took low-estrogen or regular birth control pills. Investigators theorize that when women are not on the pill, their natural estrogen levels go up and down, which seems to prevent the eye from developing glaucoma.  When women go on the pill, their estrogen levels are consistent, and in some cases consistently low, which could cause them to develop the condition.

This research project is the first to suggest an increased risk of glaucoma in women who have used oral contraceptives for three or more years. The researchers looked at data on more than 3,400 women aged 40 and older from across the United States, who answered questionnaires about their reproductive health and eye exams.

“We believe at this point, by analyzing the data, there is an association between long-term birth control use and glaucoma,”  said Elaine Wang, of Duke University and an author of the study.

“Why?  We’re not sure. The next step is to examine the eyes carefully and look at exactly what is happening to a woman’s vision when she’s on birth control pills.  We need to verify these findings.”

Although study authors say more research needs to be done, they do stress that gynecologists and ophthalmologists need to be aware of the fact that oral contraceptives may play a role in glaucomatous diseases.  They believe doctors should make sure their female patients have their eyes screened for glaucoma, especially if they also have other risk factors, such as race, (African-Americans are at highest risk) family history of glaucoma or a history of increased eye pressure problems.

“This study should be an impetus for future research to prove the cause and effect of oral contraceptives and glaucoma,” said Dr. Shan Lin, lead researcher and professor of clinical ophthalmology at the University of California, San Francisco. “At this point, women who have taken oral contraceptives for three or more years should be screened for glaucoma and followed closely by an ophthalmologist, especially if they have any other existing risk factors.”

Because glaucoma affects 60 million people worldwide and is the leading cause of bilateral blindness, second only to cataracts, screening for the condition is encouraged for all people, especially over the age of 50. Although it can be treated, doctors say any new information on glaucoma is important.

“This supports the importance of getting screened, especially if you fall into the high risk category,” noted Dr. Thomas Yau, an ophthalmologist from Silver Spring, Maryland, and a member of the American Academy of Ophthalmology .  “It brings to the equation a possible new risk factor for glaucoma. Should we be raising the red flag?  Not yet, but birth control use should be looked at as a possible risk when talking to patients.”

The research was presented Monday at the annual meeting of the American Academy of Ophthalmology.

Post by:

Less Is More: One, Instead of Three Doses of HPV Vaccine May Protect Against Cervical Cancer Read more: One Dose of HPV Vaccine May Protect Against Cervical Cancer

Less Is More: One, Instead of Three Doses of HPV Vaccine May Protect Against Cervical Cancer Read more: One Dose of HPV Vaccine May Protect Against Cervical Cancer

2013-11-05

By

Public-health officials may not have to worry so much about the low percentage of girls who don’t get all three doses of the human papillomavirus (HPV) vaccine.

The HPV vaccine is one of the best ways to prevent genital warts and infection with the virus that can cause cervical cancer, so since 2007, the Centers for Disease Control and Prevention recommended girls get three doses of the shot when they are 11 or 12 years old, and since 2011, advised that boys of the same age get routinely immunized as well. But about a third of eligible young people in the U.S. start the three-shot regimen, which takes six months to complete, and never complete the schedule; around half of eligible children are fully immunized against HPV.

Cost — all three doses of the immunization cost about $400 — and the lack of follow-up over six months contribute to the low compliance rate, so scientists have been investigating whether fewer doses could protect against infection just as well. A 2011 study reported that people had similar levels of protection at two doses, and now researchers believe even one shot may be enough.

The researchers studied Cervarix, which, like the other HPV vaccine approved by the Food and Drug Administration, Gardasil, protects against HPV subtypes 16 and 18. The researchers measured the immune response to the vaccine in groups of 78, 192 and 120 women who received one, two and three doses of the vaccine, respectively. They then compared the amount of antibodies these women produced against those of a group of 113 women who did not get immunized but had been infected with HPV at some point in their lives.

The vaccinated women in all three groups continued to show HPV antibodies in their blood for up to four years. These levels were similar among women who received two doses and those who were vaccinated with all three doses. But the women who just got one dose also had stable antibody levels, even though they were lower than those found in the other groups. These levels, however, were still 24 times higher than those among women who never received the vaccine but had been infected with the virus. So a single dose of the vaccine, the researchers believe, may be sufficient to provide some protection against infection with HPV.

They still aren’t sure, however, whether the antibodies generated by the vaccine are sufficient for long-term protection, such as that provided by immunizations against hepatitis A and polio, or whether people will need to boost waning levels of antibodies with additional shots over time.

There are hints that three doses may not be necessary, however. In Chile and British Columbia, public-health officials recommend just two doses of the HPV vaccine. But before the current recommendation in the U.S. is changed, more research is needed to clarify what type of protection the vaccines provide, and whether there are differences between the two currently approved shots. So for now, it’s not likely that the needle-phobic will get a break when it comes to getting up to date on their HPV shots.

New Definition of “Full-Term” Pregnancy Presents Other Problems

New Definition of “Full-Term” Pregnancy Presents Other Problems

2013-10-23

By @ProfEmilyOsterOct. 22, 2013

Big news for women who are 38 weeks pregnant: you are no longer considered “full term.” The American College of Obstetricians and Gynecologists (ACOG) announced today that they would introduce a new classification system for the end of pregnancy.  Previously women who were 37 to 41 weeks pregnant were all considered “Full Term” and women 42+ weeks “Post-term”.  The new classification system calls for four groups:  “Early Term” (37-38 weeks), “Full Term” (39-40 weeks), “Late Term” (41 weeks) and “Post-term” (42+weeks).

I know, that’s a lot of terms. But the big change here is to separate out the 37 to 38 week period and acknowledge that, for most babies, this isn’t the ideal time to be born. Evidence has been piling up that babies born in this period do worse than babies born at 39 or 40 weeks. One very recent paper shows babies at 37 to 38 weeks are more likely than those born later to need time in the NICU, mechanical ventilation and IV fluids. But as induction and scheduled C-sections have become more common, the share of babies born at 37 or 38 weeks has risen from 17% in 1983 to 27% in 2009. Many of these deliveries are elective and driven, at least in part, by the perception by women (or their doctors) that things are ready to go at 37 weeks. The push to reduce these early-term deliveries has been going on for years.

This change in wording could make a big difference in practice. Early term births are expensive because of their added complications and by explicitly distinguishing them it makes it easier for insurers to refuse to cover elective births in this period. The problem, however, with having a strict guideline like this is that sometimes people start to treat it the cutoff itself as meaningful.

It is worth reflecting back on why this change is even necessary.  The idea that 37 weeks is “full term” is intended to be descriptive.  As pregnancy moves forward, the baby becomes more developed.  Among the last organs to develop are the lungs, and usually this happens by 37 weeks, so calling 37 weeks “full term” is simply an acknowledgement of this. But women, and their doctors, can start to think that when you move from 36 weeks 7 days pregnant to 37 weeks 0 days pregnant there is a magic switch which means your baby is ready.  This is obviously not the case.

This is illustrative of a broader issue, in medicine and elsewhere, with any kind of sharp rule-like cutoff.  In one example, researchers have shown that as a result of drawing the cutoff for very low birth weight at 1500 grams, babies born right below 1500 grams of weight actually have better outcomes than those right above, because they are given extra treatment.  Again, there is nothing biologically special about 1500 versus 1499.  The cutoff is descriptive, and when it’s treated as a rule, odd things happen. The same issues come up in finance, closer to my own field, when looking at lenders who used sharp cutoffs in credit scores in deciding who to lend to.  There is nothing special about a credit score of 620 compared to 619, and when you treat it like there is, you can get into trouble.

The worry, of course, to return to the babies, is that what is happening here is we are replacing one rule with another. The new guidelines fix one issue, but could lead doctors (in theory) to be too cautious about delivery in 37 or 38 weeks when medically warranted. It could also lead them to be too gung-ho about delivery as soon as you hit 39 weeks. The best case would be if women and their doctors took these terms as they are intended— as descriptive guidelines, not rules—and got better about letting nature take its course unless there is a medical reason not to.  If that happens, this truly will be a major change, and not just for the women at 38 weeks.

 

Pregnant woman holding belly
Pregnant woman holding belly